Skip to main content
SpringerLink
Log in

Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration

  • Case Report
  • Published:
Annals of Ophthalmology

Abstract

We report the development of a large subretinal hemorrhage 4 weeks after intravitreal bevacizumab in an 84-year-old male with 20/70 visual acuity caused by occult choroidal neovascularization from neovascular agerelated macular degeneration in one eye that was treated with 1.25 mg of intravitreal bevacizumab.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805–2816.

    Article  PubMed  CAS  Google Scholar 

  2. Avery RL, Pieramici DJ, Rabena MD, et al. Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmology 2006;113:363–372.

    Article  PubMed  Google Scholar 

  3. Rich RM, Rosenfeld PJ, Puliafito CA, et al. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration. Retina. 2006;26(5):495–511.

    Article  PubMed  Google Scholar 

  4. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383–390.

    Article  PubMed  Google Scholar 

  5. Bashshur ZF, Bazarbachi A, Schakal A, et al. Intravitreal bevacizumb for the management of choroidal neovascularization in age-related macular degeneration. Am J Opthalmol 2006;142:1–9.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Opthalmology, Duke University Medical Center, Durham, NC

    Jenet J. Chieh MD & Sharon Fekrat MD, FACS

Authors
  1. Jenet J. Chieh MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sharon Fekrat MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sharon Fekrat MD, FACS.

Additional information

DISCLOSURE Dr. Fekrat has stated that he has a consultant relationship with Genentech Inc., manufacturer of a drug discussed in this article. The authors also discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chieh, J.J., Fekrat, S. Large subretinal hemorrhage after intravitreal bevacizumab (Avastin®) for age-related macular degeneration. Ann Ophthalmol 39, 51–52 (2007). https://doi.org/10.1007/BF02697326

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02697326

Keywords

Search

Navigation